Journal rankings · indicator year 2014
Choose a field to open its ranking, or a journal to find its row in its subfield’s list.
Field ranking · 2014
Biochemistry, Genetics and Molecular Biology journal rankings 2014
1,217 ranked journals · Field in Life Sciences
Biochemistry, Genetics and Molecular Biology has 1,217 ranked journals in 2014. The median journal has an OJR of 0.99, below the world average of 1.00, unchanged on 2013; Q1 starts at OJR 1.51. The top three are Cell, Nature Genetics, and Pharmacological Reviews.
Ranks and citation indicators: 2014. Journal access status and listed APC: source snapshot September 23, 2026.
Journals whose main subfield sits in this category and that published at least 30 citable documents (articles, reviews and conference papers) in 2011–2013, the window the 2014 score is computed on.
The OpenJournalRank Indicator (OJR) is a free, publicly available metric of a journal’s field-normalized citation impact, computed from open OpenAlex citation data. It compares citations to a journal’s papers from the previous three years with the world average for papers of the same subfield, year and type, so 1.00 is the world average and values can be compared across fields. It is computed with the NCI3 method.
The middle OJR among ranked journals in this category: half score higher, half lower. 1.00 is the world average for papers of the same subfield, year and type.
The dot is this category, the solid tick is the median of all ranked journals and the dashed line is the world average.
Share of ranked journals in this category that are fully open access, so every paper is free to read. Hybrid journals, which sell subscriptions and open single papers for a fee, are not counted.
Median list price of the article processing charge, in US dollars, among ranked journals in this category that list a price above zero. Journals with a listed APC of $0 and journals with no known price are left out of this median. The At a glance table below gives a second median that includes the $0 prices.
Subfields in Biochemistry, Genetics and Molecular Biology (14)
Up to Life Sciences1,217 ranked journals
Filters
Rank is the position by OJR within the list on screen; 1 is the highest. | OJR is field-normalized 3-year citation impact: 1.00 is the world average for papers of the same subfield, year and type, so values compare across fields. The badge is the journal’s quartile in this list. | Citations per paper over a two-year window, counted from OpenAlex. It is not field-normalized, so compare it only between journals of the same field. ▲ or ▼ is the change from 2013. This is OpenJournalRank’s own count, not Clarivate’s Journal Impact Factor. | Citable documents (articles, reviews and conference papers) published in 2011–2013, the window the 2014 OJR is computed on. A journal needs at least 30 to be ranked. | Share of the journal’s 2011–2013 papers that are free to read in any open-access form. The green OA tag next to a title marks a fully open-access journal. | List price of the article processing charge in US dollars. “$0 listed” means the listed price is zero; a dash means no price is listed. | The line is the journal’s OJR from 2005 to 2014. | Compare |
|---|---|---|---|---|---|---|---|
1CellCell Press · United States | 10.17Q1 | 27.25 0.40 down from 2013 | 1,757 | 99% | $11,400 | ||
2Nature GeneticsNature Portfolio · United States | 9.69Q1 | 23.05 2.05 down from 2013 | 959 | 55% | $12,690 | ||
3Pharmacological ReviewsAmerican Society for Pharmacology and Experimental Therapeutics · United States | 9.48Q1 | 21.83 0.78 down from 2013 | 112 | 55% | $4,500 | ||
4Molecular Biology and EvolutionOAOxford University Press · United States | 7.53Q1 | 10.86 5.88 down from 2013 | 863 | 85% | $3,418 | ||
5NatureNature Portfolio · United Kingdom | 7.30Q1 | 13.61 0.33 down from 2013 | 9,743 | 33% | $12,690 | ||
6FEMS Microbiology ReviewsOAOxford University Press · Netherlands | 6.44Q1 | 12.73 2.46 down from 2013 | 146 | 72% | $3,297 | ||
7GigaScienceOAUniversity of Oxford · United Kingdom | 6.23Q1 | 14.91 7.72 up from 2013 | 32 | 100% | $2,638 | ||
8Nature CommunicationsOANature Portfolio · United Kingdom | 6.14Q1 | 13.86 0.56 up from 2013 | 2,759 | 99% | $6,990 | ||
9Systematic BiologyOxford University Press · United States | 6.05Q1 | 12.57 2.49 up from 2013 | 294 | 51% | $2,166 | ||
10Nature BiotechnologyNature Portfolio · United States | 5.69Q1 | 12.34 1.15 up from 2013 | 1,121 | 32% | $12,690 | ||
11ScienceAmerican Association for the Advancement of Science · United States | 5.65Q1 | 8.97 0.47 up from 2013 | 11,811 | 22% | — | ||
12Cell MetabolismCell Press · United States | 5.57Q1 | 16.39 1.26 up from 2013 | 600 | 100% | $10,400 | ||
13Molecular Systems BiologyOASpringer Nature · United Kingdom | 5.55Q1 | 12.30 3.55 down from 2013 | 253 | 100% | $7,990 | ||
14Cell stem cellElsevier BV · United States | 5.53Q1 | 15.46 0.52 down from 2013 | 603 | 100% | $10,400 | ||
15Nature Cell BiologyNature Portfolio · United Kingdom | 5.52Q1 | 14.19 0.65 down from 2013 | 685 | 56% | $12,690 | ||
16Journal of Clinical InvestigationOAAmerican Society for Clinical Investigation · United States | 5.27Q1 | 13.52 0.10 down from 2013 | 1,575 | 100% | $5,200 | ||
17Molecular Aspects of MedicineElsevier BV · United Kingdom | 5.20Q1 | 11.85 0.62 up from 2013 | 150 | 25% | $5,220 | ||
18Progress in Lipid ResearchElsevier BV · United Kingdom | 5.17Q1 | 11.73 1.36 down from 2013 | 90 | 26% | $5,530 | ||
19Biotechnology AdvancesElsevier BV · United Kingdom | 5.08Q1 | 10.22 0.43 down from 2013 | 402 | 21% | $5,460 | ||
20Nature MethodsNature Portfolio · United States | 5.05Q1 | 13.92 2.47 up from 2013 | 1,254 | 34% | $12,690 | ||
21MicrobiomeOABioMed Central · United Kingdom | 4.89Q1 | 10.42no 2013 value | 31 | 100% | $4,990 | — | |
22Proceedings of the National Academy of SciencesNational Academy of Sciences · United States | 4.59Q1 | 10.75 0.25 down from 2013 | 12,647 | 100% | — | ||
23Cell Host & MicrobeCell Press · United States | 4.55Q1 | 11.18 0.25 up from 2013 | 465 | 100% | $10,400 | ||
24The American Journal of Human GeneticsElsevier BV · United States | 4.51Q1 | 11.38 0.15 up from 2013 | 759 | 97% | $5,150 | ||
25Nature ProtocolsNature Portfolio · United States | 4.51Q1 | 12.11 1.76 up from 2013 | 521 | 45% | — | ||
26Studies in MycologyElsevier BV · Netherlands | 4.44Q1 | 11.14 2.92 up from 2013 | 63 | 100% | $1,430 | ||
27Molecular CellElsevier BV · United States | 4.42Q1 | 13.52 0.38 up from 2013 | 1,124 | 100% | $10,400 | ||
28Drug Resistance UpdatesElsevier BV · United Kingdom | 4.29Q1 | 11.64 0.43 down from 2013 | 57 | 28% | $5,410 | ||
29Pharmacology & TherapeuticsElsevier BV · United States | 4.25Q1 | 11.38 1.64 up from 2013 | 331 | 37% | $5,660 | ||
30Science Translational MedicineAmerican Association for the Advancement of Science · United States | 3.84Q1 | 9.49 0.65 up from 2013 | 1,405 | 32% | — | ||
31Nature Structural & Molecular BiologyNature Portfolio · United States | 3.78Q1 | 11.04 0.75 up from 2013 | 757 | 58% | $12,690 | ||
32TrAC Trends in Analytical ChemistryElsevier BV · Netherlands | 3.74Q1 | 6.65 0.29 up from 2013 | 527 | 11% | $5,150 | ||
33eLifeOAeLife Sciences Publications Ltd · United Kingdom | 3.69Q1 | 8.76 1.40 up from 2013 | 358 | 100% | $2,500 | ||
34Expert Reviews in Molecular MedicineOACambridge University Press · United Kingdom | 3.67Q1 | 6.91 0.75 down from 2013 | 70 | 26% | $3,550 | ||
35Cell ReportsOACell Press · United States | 3.66Q1 | 10.06 0.85 up from 2013 | 739 | 100% | $5,620 | ||
36PLoS BiologyOAPublic Library of Science · United States | 3.62Q1 | 8.21 1.83 down from 2013 | 785 | 100% | $5,500 | ||
37Journal of Extracellular VesiclesOATaylor & Francis · United States | 3.51Q1 | 8.90 6.44 up from 2013 | 50 | 100% | $4,410 | ||
38Genome biologyOABioMed Central · United Kingdom | 3.48Q1 | 10.02 2.25 up from 2013 | 785 | 100% | $5,490 | ||
39Cancer ResearchAmerican Association for Cancer Research · United States | 3.46Q1 | 9.49 0.63 down from 2013 | 2,224 | 7% | — | ||
40PLoS GeneticsOAPublic Library of Science · United States | 3.41Q1 | 8.82 0.97 down from 2013 | 2,167 | 100% | $3,043 | ||
41mBioOAAmerican Society for Microbiology · United States | 3.41Q1 | 7.66 0.04 down from 2013 | 597 | 100% | $3,900 | ||
42Circulation ResearchLippincott Williams & Wilkins · United States | 3.39Q1 | 9.07 0.97 down from 2013 | 1,118 | 39% | — | ||
43The EMBO JournalOASpringer Nature · Germany | 3.38Q1 | 9.71 0.79 down from 2013 | 1,111 | 99% | $7,990 | ||
44Nucleic Acids ResearchOAOxford University Press · United Kingdom | 3.36Q1 | 9.73 0.19 up from 2013 | 4,170 | 100% | $3,992 | ||
45Scientific ReportsOANature Portfolio · United Kingdom | 3.36Q1 | 7.17 0.22 up from 2013 | 3,487 | 100% | $2,690 | ||
46Physiological ReviewsAmerican Physiological Society · United States | 3.34Q1 | 36.19 2.92 down from 2013 | 108 | 45% | — | ||
47EMBO Molecular MedicineOASpringer Nature · United Kingdom | 3.33Q1 | 9.28 1.28 up from 2013 | 344 | 100% | $7,990 | ||
48Biochimica et Biophysica Acta (BBA) - Reviews on CancerElsevier BV · Netherlands | 3.32Q1 | 10.00 1.51 up from 2013 | 144 | 37% | $5,070 | ||
49BiomedicineOAEDP Sciences · Netherlands | 3.32Q1 | 7.75 6.64 up from 2013 | 66 | 100% | — | ||
50Developmental CellElsevier BV · United States | 3.26Q1 | 8.66 0.22 down from 2013 | 779 | 100% | $10,400 |
Subfields of Biochemistry, Genetics and Molecular Biology, compared.
- Molecular Biology1,034
- Genetics108
- Cell Biology25
- Cancer Research23
- Molecular Medicine10
- Biophysics7
- Clinical Biochemistry3
- Biochemistry2
- Structural Biology2
- Aging1
- Developmental Biology1
- Physiology1
- Biotechnology0
- Endocrinology0
Journals
Citations made in 2014. Corpus-wide, 77.7% of core-journal articles and reviews published that year have at least one matched reference; the share varies by journal and field.
444 additional Biochemistry, Genetics and Molecular Biology journals with metrics are unranked under this release’s eligibility rules: a journal needs at least 30 citable documents in 2011–2013, at least 80% of them with a subfield, and a positive world-average expectation. Ranks are within the whole category; filters hide rows without re-ranking. OJR excludes self-citations.
At a glance
Indicator year: 2014. Publication window: 2011–2013. How these summaries are calculated
- Ranked journals
- 1,217
- Window papers (baseline)
- 652,778 +9.7% from indicator year 2011
- Median OJR
- 0.986 -3.9% from indicator year 2011
- Rising journals (2025)
- 141Comparison-group list (141)
Window papers are the baseline paper population: citable papers (articles, reviews and conference papers) from 2011–2013 in all journals of the world-average baseline, including non-core journals, counted by each paper’s own subfield. They are not the papers of the ranked journals alone.
| Measure | Year series | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ranked journals | 609 | 650 | 696 | 742 | 765 | 806 | 835 | 888 | 919 | 951 | 1,003 | 1,064 | 1,125 | 1,172 | 1,217 | 1,271 | 1,311 | 1,339 | 1,365 | 1,369 | 1,349 | 1,339 | 1,358 | 1,366 | 1,355 | 1,367 | |
| Window papers (baseline) | 310,927 | 335,262 | 354,210 | 375,343 | 388,415 | 415,247 | 441,606 | 472,036 | 497,712 | 532,780 | 565,943 | 595,190 | 615,359 | 631,115 | 652,778 | 672,042 | 683,714 | 684,441 | 678,826 | 679,352 | 690,127 | 717,801 | 750,552 | 768,440 | 764,327 | 768,613 | |
| Median OJR | 0.628 | 0.634 | 0.68 | 0.76 | 0.81 | 0.8465 | 0.872 | 0.894 | 0.921 | 0.95 | 0.98 | 1.03 | 1.02 | 0.990 | 0.986 | 0.97 | 0.96 | 0.93 | 0.925 | 0.915 | 0.912 | 0.90 | 0.890 | 0.8474 | 0.853 | 0.871 |
| Measure | Category statistic | Eligible population |
|---|---|---|
| Journal self-citation share | Median: 1.9% | 1,206 journals |
| Retracted papers per 1,000 | Pooled rate: 4.798 per 1,000 | 1,059 journals |
| Output growth | Median: -6.4% | 1,233 journals |
| Open access share | Median: 100.0% | 1,367 journals |
| Listed APC (USD) | Median including $0 listed prices: $3,300 | 943 ranked journals with a known listed price, including $0 listed prices |
| International collaboration share | Median: 24.4% | 1,335 journals |
| Review share | Median: 0.3% | 1,367 journals |
| Articles-only OJR | Median: 0.87 | 1,336 journals |
| Uncited share | Median: 22.7% | 1,367 journals |
| Citation concentration | Median: 42.1% | 1,363 journals |
How to read these rankings
- OJR, the OpenJournalRank Indicator
- A field-normalized 3-year citation impact, computed from OpenAlex with the NCI3 method. It divides the citations a journal’s papers received by the world average for papers of the same subfield, year and type, so 1.00 is the world average and 2.00 means twice as many citations as expected. Because it is normalized, it can be compared across fields. Read the methodology
- Quartiles
- Q1 to Q4 split the ranked journals of the list you are viewing into four equal groups by OJR. A journal’s quartile depends on the list: the same journal can be Q1 in its subfield and Q2 among all journals.
- Impact factor (2-year)
- Citations per paper over a two-year window, counted from OpenAlex. It is easy to compare with familiar impact factors but is not field-normalized, so compare it only within a field. It is not Clarivate’s Journal Impact Factor. Why it differs from the Journal Impact Factor
- Rank ranges
- Each rank in the latest year carries a likely range from 1,000 resamples of the journal’s papers. Where two journals’ ranges overlap, the data cannot tell them apart, so treat neighbouring ranks as ties.